Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 152,600
  • Shares Outstanding, K 89,240
  • Annual Sales, $ 27,860 K
  • Annual Income, $ -14,230 K
  • EBIT $ -32 M
  • EBITDA $ -33 M
  • 60-Month Beta 2.86
  • Price/Sales 22.45
  • Price/Cash Flow N/A
  • Price/Book 3.58

Options Overview Details

View History
  • Implied Volatility 167.98% (-50.30%)
  • Historical Volatility 82.41%
  • IV Percentile 49%
  • IV Rank 25.28%
  • IV High 664.40% on 09/19/25
  • IV Low 0.01% on 09/08/25
  • Expected Move (DTE 7) 0.8160 (48.86%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 42
  • Volume Avg (30-Day) 68
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 3,503
  • Open Int (30-Day) 3,338
  • Expected Range 0.8540 to 2.4860

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.05
  • Number of Estimates 5
  • High Estimate 0.56
  • Low Estimate -0.08
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +171.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5800 +5.70%
on 02/05/26
2.3800 -29.83%
on 01/16/26
-0.3100 (-15.66%)
since 01/12/26
3-Month
1.4300 +16.78%
on 12/30/25
2.3800 -29.83%
on 01/16/26
-0.0100 (-0.60%)
since 11/12/25
52-Week
1.1300 +47.79%
on 04/09/25
2.3800 -29.83%
on 01/16/26
-0.5200 (-23.74%)
since 02/12/25

Most Recent Stories

More News
Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

HOLON, Israel , Feb. 12, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered...

CGEN : 1.6700 (-2.34%)
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million

HOLON, Israel , Dec. 17, 2025 /PRNewswire/ --  Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.6700 (-2.34%)
Compugen: Q3 Earnings Snapshot

Compugen: Q3 Earnings Snapshot

CGEN : 1.6700 (-2.34%)
Compugen Reports Third Quarter 2025 Results

HOLON, Israel , Nov. 10, 2025 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.6700 (-2.34%)
Compugen to Participate in Stifel 2025 Healthcare Conference

HOLON, Israel , Nov. 4, 2025 /PRNewswire/ --  Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 1.6700 (-2.34%)
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025

HOLON, Israel , Oct. 27, 2025 /PRNewswire/ --  Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 1.6700 (-2.34%)
Analysts Offer Insights on Healthcare Companies: Compugen (CGEN) and AbbVie (ABBV)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compugen (CGEN – Research Report) and AbbVie (ABBV – Research Report) with bullish sentiments.Elevate...

CGEN : 1.6700 (-2.34%)
ABBV : 227.50 (+2.99%)
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025

HOLON, Israel , Oct. 13, 2025 /PRNewswire/ --  Compugen Ltd.  (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.6700 (-2.34%)
Compugen to Present at SITC 2025

HOLON, Israel , Oct. 6, 2025 /PRNewswire/ -- Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery,...

CGEN : 1.6700 (-2.34%)
Compugen to Present Research at the Single Cell Genomics 2025 Conference

HOLON, ISRAEL , Sept. 8, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational...

CGEN : 1.6700 (-2.34%)

Business Summary

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas...

See More

Key Turning Points

3rd Resistance Point 1.7818
2nd Resistance Point 1.7434
1st Resistance Point 1.7067
Last Price 1.6700
1st Support Level 1.6316
2nd Support Level 1.5932
3rd Support Level 1.5565

See More

52-Week High 2.3800
Fibonacci 61.8% 1.9025
Fibonacci 50% 1.7550
Last Price 1.6700
Fibonacci 38.2% 1.6075
52-Week Low 1.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar